-
Mashup Score: 2Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer - 24 day(s) ago
npj Precision Oncology – Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer
Source: www.nature.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 2Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer - 24 day(s) ago
npj Precision Oncology – Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer
Source: www.nature.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 5
PURPOSE We report the clinical outcomes of a randomized trial comparing prophylactic whole-pelvic nodal radiotherapy to prostate-only radiotherapy (PORT) in high-risk prostate cancer. METHODS This phase III, single center, randomized controlled trial enrolled eligible patients undergoing radical radiotherapy for node-negative prostate adenocarcinoma, with estimated nodal risk ≥ 20%. Randomization was 1:1 to PORT (68 Gy/25# to prostate) or whole-pelvic radiotherapy (WPRT, 68 Gy/25# to prostate, 50 Gy/25# to pelvic nodes, including common iliac) using computerized stratified block randomization, stratified by Gleason score, type of androgen deprivation, prostate-specific antigen at diagnosis, and prior transurethral resection of the prostate. All patients received image-guided, intensity-modulated radiotherapy and minimum 2 years of androgen deprivation therapy. The primary end point was 5-year biochemical failure-free survival (BFFS), and secondary end points were disease-free survival
Source: ascopubs.orgCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 9Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer - 2 month(s) ago
Author links open overlay panel Bernard Pope a b c d ‡, Gahee Park e f g ‡, Edmund Lau a b, Jelena Belic e f g, Radoslaw Lach e f g, Anne George g h i j k, Patrick McCoy a, Anne Nguyen a, Corrina Grima a, Bethany Campbell a, Chol-hee Jung b, Emma-Jane Ditter f l, Hui Zhao f l, The Pan Prostate Cancer Group (PPCG) m, David C. Wedge n, Daniel S. Brewer o p, Andy G. Lynch q r, Harveer Dev e f g, Vincent J. Gnanpragasam h i k, Nitzan Rosenfeld f l … Charles E. Massie e f g § † There are more references
Source: www.sciencedirect.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 9Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer - 2 month(s) ago
Author links open overlay panel Bernard Pope a b c d ‡, Gahee Park e f g ‡, Edmund Lau a b, Jelena Belic e f g, Radoslaw Lach e f g, Anne George g h i j k, Patrick McCoy a, Anne Nguyen a, Corrina Grima a, Bethany Campbell a, Chol-hee Jung b, Emma-Jane Ditter f l, Hui Zhao f l, The Pan Prostate Cancer Group (PPCG) m, David C. Wedge n, Daniel S. Brewer o p, Andy G. Lynch q r, Harveer Dev e f g, Vincent J. Gnanpragasam h i k, Nitzan Rosenfeld f l … Charles E. Massie e f g § † There are more references
Source: www.sciencedirect.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 7
Darolutamide is an androgen receptor inhibitor that increases overall survival in combination with androgen deprivation therapy (ADT) in patients with…
Source: www.sciencedirect.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 7
Darolutamide is an androgen receptor inhibitor that increases overall survival in combination with androgen deprivation therapy (ADT) in patients with…
Source: www.sciencedirect.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 7
Darolutamide is an androgen receptor inhibitor that increases overall survival in combination with androgen deprivation therapy (ADT) in patients with…
Source: www.sciencedirect.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 4Royal Statistical Society Publications - 4 month(s) ago
Statistical issues in conducting randomized trials include the choice of a sample size, whether to stop a trial early and the appropriate analysis and interpretation of the trial results. At each of …
Source: rss.onlinelibrary.wiley.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 4Royal Statistical Society Publications - 4 month(s) ago
Statistical issues in conducting randomized trials include the choice of a sample size, whether to stop a trial early and the appropriate analysis and interpretation of the trial results. At each of …
Source: rss.onlinelibrary.wiley.comCategories: General Medicine News, Oncologists2Tweet
RT @ClemLeMagnen: Now published at @Nature_NPJ precision oncology: https://t.co/21VVUb7oOv